Tag: Biovie

April 30, 2019

BioVie shared top-line results for its Phase 2a clinical trial of BIV201 in patients with refractory ascites due to advanced liver cirrhosis.

January 16, 2018

BioVie (OTCQB: BIVI), reviewed key milestones achieved over the past year and provided a general update on the progress of...